eScholarshipmetadata only
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
31 biological sciences (for-2020), genetics (rcdc), cancer (rcdc), gene therapy (rcdc), bioengineering (rcdc), immunotherapy (rcdc), biotechnology (rcdc), 5.2 cellular and gene therapies (hrcs-rac)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 922264
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.